DOSIS_Updated_Agreement.pdf

Purchase and Monthly Subscription Agreement for DOSIS Systems

As used herein, the following terms shall have the meanings set forth:

Additional Covered Technology. Any DOSIS equipment previously acquired by Subscriber and specifically listed in Exhibit B for which Manchac agrees to provide Customer Care Services during the Term of this Agreement.

Agreement. The DOSIS Purchase and Maintenance Agreement between Manchac and Subscriber.

Docusign Envelope ID: 1 E4D5776-4C05-4949-B818-EAE335D1 B2D1

D (i)SIS*svstems

Manchac Technologies, L.L.C. {Manchac), a Louisiana Limited Liability Company located at 1115 Second Street, Alexandria, LA 71301, offers a DOSIS® system and related Customer Care Services to the Subscriber for Purchase and Monthly Maintenance (Subscription). This DOSIS System is offered on the pricing, terms and conditions set forth herein, which are accepted by Subscriber as a condition of use of the system on August 15. 2025

Subscriber: Ohio Department of Behavioral Health Address for Notices: Ohio Department of Behavioral Health

2150 West Broad Street Columbus, OH 43223 Account #: 20056

SECTION 1- DEFINITIONS

Attn: Timothy Bodle 2150 West Broad Street Columbus, OH 43223 tom.barthlow@mha.ohio.gov

Customer Care Services. Throughout the Term, Manchac agrees to provide support services, including telephone, email, and online support during Normal Operating Hours; technical analysis and consultation related to operation and optimization of DOSIS System;

adjustments to custom software configuration of DOSIS System including label templates, work flow rules, and existing interfaces;

updates to hardware and software; and repair work and replacement components as determined necessary by Manchac for proper performance of DOSIS System.

DOSIS® and DOSIS System are equivalent terms and are defined as the Provided Technology including but not limited to related DOSIS equipment, Software (operating system, interfaces, application software, web pages), and documentation.

Installation. The process during which the DOSIS System is physically installed within the dispensing pharmacy, as well establishing connectivity with pharmacy's local network, the PMS, and Manchac's remote support servers. Installation is deemed complete at the point at which Subscriber's DOSIS System completes Manchac's acceptance testing including, but not limited to, successful completion of filling, labeling and sealing a battery of sample prescriptions, and system is ready for use by Pharmacy. Additional on-site Training may immediately follow Installation.

Licensed Products. The DOSIS operating system, DOSIS application software, and DOSIS browser-based interface. See Section 3.6.

Monthly Maintenance. Same as Monthly Subscription Monthly Subscription. As listed in Exhibit B, the total payment due each month per the terms of Section 2.1.

Normal Operating Hours are US Central Time, 7 am to 7 pm Monday through Friday and 8 am to 5 pm on Saturday except for Observed Holidays.

Observed Holidays are typically New Year's Day, Good Friday, Memorial Day, Independence Day, Labor Day, Thanksgiving Day, Day after Thanksgiving Day, Christmas Eve, Christmas Day, and New Year's Eve. Current Observed Holidays can be provided by Manchac upon request.

PMS. The Pharmacy Management Software (PMS) which the Pharmacy uses to conduct their regular business of processing prescription transactions and to which DOSIS will interface. The PMS is also commonly referred to as the pharmacy host system.

Provided DOSIS Technology. As listed in Exhibit B, the DOSIS System including hardware and software supplied by Manchac under the terms of this Agreement.

Software. The proprietary software system is designed and owned by Manchac and provided as part of the DOSIS System. The Software License Agreement in Section 3.6 sets the use parameters of the Software.

Subscriber. As defined in the heading on page 1.

Training. The process by which Manchac provides instruction on usage, maintenance, troubleshooting, and performance analysis of the DOSIS System. Manchac provides one-time, comprehensive, on-site training for the pharmacy staff typically in conjunction with Installation. Additional remote Training may be provided via video or telephone conferencing throughout Term. Additional on-site Training may be provided for additional cost.

Updates. Hardware and/or software modifications that improve or correct the DOSIS System during the Term. See Section 3.4 Design Changes.

Upgrades. Hardware and/or software modifications to DOSIS System that provide additional benefits and enhancements to DOSIS; these upgrades are not necessary to the proper functioning of the DOSIS unit and are available at additional cost or a revised Subscription Agreement.

Page 1 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024

1.

Docusign Envelope ID: 1E4D5776-4C05-4949-B818-EAE335D182D1

User Documentation. Electronically provided instructions and usage guides as included on the DOSIS System and accessible by Subscriber throughout Term.

SECTION 2 - PAYMENT TERMS

2. Payments. The fee for the DOSIS Project Package is due at the time of execution of this Agreement. Subscriber will be responsible for making Monthly Subscription payments for which equipment and/or services are to be provided over the Term of the Agreement.

Manchac shall submit monthly invoices to Subscriber. All invoices shall contain Subscriber's name and address and shall reference OhioMHAS and list the billing address as Ohio Department of Behavioral Health, 2150 West Broad Street, Columbus, Ohio 43223, Attention: Timothy Bodle. After receipt and approval of each invoice, payment will be made.

As the current Ohio General Assembly cannot commit a future General Assembly to expenditure, the Term of this Agreement begins on or after the date of an approved purchase order and expires June 30, 2027. Subscriber shall timely pay all obligations in accordance with the prices outlined in this Agreement., subject to Ohio Revised Code 126.30. Subscriber agrees that Manchac may deactivate any provided equipment or services upon Subscriber's failure to pay such obligations.

Prior to expiration, Subscriber may renew this Agreement for an additional term of up to two years (i.e., beginning July 1, 2027, and ending June 30, 2029) on the same terms and conditions by giving Manchac written notice of Subscriber's desire to renew.

2.2. Additional Costs. In addition to the Monthly Subscription payment, Subscriber is responsible for any and all cost of the following:

• Pharmacy Automation Interface provided by Pharmacy Management System (PMS) vendor

• Additional/on-going supply of consumables

• Insurance to cover potential loss or damage to DOSIS System while on Subscriber's premises

• Building, fixtures, utility, and PMS software modifications.

SECTION 3 - STANDARD TERMS AND CONDITIONS

3.1. Title and Ownership. Title to the purchased DOSIS System will belong to the Subscriber and Title to licensed products including but not limited to software or other provided technology will remain with Manchac or its affiliated equipment holding partners (Owner).

3.2. Breach and Enforcement. Either party may terminate the initial term if a party materially breaches its obligations under this agreement with a 90-days written notice in accordance with the 3.11 Notices indicating the cause of the breach and such breach is not cured within 60-days of notice. Any period extending beyond the Initial Term shall be on a month-to-month basis and may be terminated without cause with a 90-days written notice as described in accordance with the 3.11 Notices.

In the event of default in any payment due, then, following written notice from Manchac to Subscriber and the expiration often (10) days without Subscriber curing such default, Subscriber shall be in default hereunder and Manchac shall be entitled to pursue all remedies which it may have against Subscriber under this Agreement and applicable law, including under the Uniform Commercial Code. In the event of a breach by any party to this Agreement of its obligations under this Agreement, any party injured by such breach, shall be entitled to exercise all rights granted hereunder and by law. Each party agrees to be responsible for any personal injury or property damage caused solely by its negligent acts or omissions as determined by a court of competent jurisdiction or as the parties may otherwise mutually agree.

3.3. Operation. The equipment and software comprising a DOSIS System are designed to perform the operation delineated in the specifications as outlined in the User Documentation and maintained in accordance with its specifications as outlined in the User Documentation and Minimum Site Requirements. In the event Subscriber uses DOSIS in ways other than as set forth in the User Documentation all warranties, express or implied, shall be terminated and waived by Subscriber; and in such event, Manchac may, at its sole option, terminate this Agreement and recover the provided equipment.

3.3.1. Minimum Site Specifications. To achieve optimal operation, DOSIS requires an environment as listed in Section 4. Manchac is not responsible for nor may be held liable for damages due to improper operating environment.

3.3.2. Site Preparation. Subscriber is responsible for ensuring that the building, supports and equipment (other than DOSIS System) at the installation site are suitable for DOSIS System and its related software and other Licensed Products. Subscriber must make required alterations to buildings, supports and the equipment (other than DOSIS System), including cutting, forming, and repairing any necessary floor, ceiling, wall, or roof openings. Subscriber is responsible for the completeness and accuracy of architectural drawings as furnished by it to Manchac and is responsible for providing timely and complete information regarding location of relevant utility lines, equipment, traffic paths and other data, including product information, required for proper execution of the work. Costs for correction due to incomplete, inaccurate, or untimely information will be borne by Subscriber. Subscriber will furnish electrical

Page 2 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024

D(i)SIS*svstems service as required and as specified by the Manchac to the equipment comprising DOSIS System. Subscriber warrants that all electrical services and wiring in the premises meet or exceed all applicable building and electrical codes applicable to new constructions at the location of installation. Subscriber will provide, install, and connect all data cables and other wiring, and provide and install any Pharmacy Managements Software (PMS) or software needed to interface its host computer or other peripheral computer equipment with DOSIS System. This includes appropriate bar-code printing equipment and any PMS modifications necessary to conform to the DOSIS interface specifications as provided by Manchac.

3.3.3. Installation. Manchac will supply all necessary tools, ladders and necessary installation equipment and Subscriber will furnish at the installing site, without charge, electricity at 120-volt, single phase, 60 cycle, for field cutting, drilling and assembly, water, heat, and light as may be needed for the installation work, fire protection of the equipment, and standby labor, if required. Manchac is to have reasonable use of any elevators and/or crane service, if available and needed, and will reimburse Subscriber for its cost for use by Manchac. Manchac will have complete free and uninterrupted, although supervised, access to the related storage and work areas, including overhead, during the installation scheduled period.

3.4. Design Changes. Manchac reserves the right to make changes in design, material and software which may improve the DOSIS System, the Licensed Products, or any component thereof and/or its operation before and/or after Installation, but in no event is Manchac obligated to do so. Manchac retains the right, in its sole discretion, to retrofit any DOSIS System to meet new design requirements during the term of this Agreement. If Subscriber makes any changes to DOSIS System which are unapproved by Manchac, Manchac shall be relieved from any warranty, express or implied, as to operation of the portion of DOSIS System affected by such changes. Manchac is not responsible for nor may be held liable for damages due to unauthorized modification by the subscriber.

3.5. Confidentiality and System Modifications. Subscriber acknowledges that any Confidential Information of Manchac disclosed to Subscriber in relation to the negotiation of this Agreement, delivery, installation, and use of DOSIS System and the software and other Licensed Products related thereto shall remain the proprietary property of Manchac and shall be treated by Subscriber as such.

Subscriber shall not use or disclose (directly or indirectly) any Confidential Information (whether or not developed or modified by Subscriber or any of its employees or agents) at any time or in any manner except as specifically authorized in writing by Manchac.

Disclosure of Manchac's Confidential Information to Subscriber's employees and agents shall only be made on a need-to-know basis and only after such employee or agent has agreed in writing to be bound by the terms of this Section to the same extent as Subscriber.

The obligations of this Section are continuing and shall survive the termination of this Agreement.

Confidential Information shall mean all ideas, concepts, inventions, devices, designs, apparatus, machines, practices, processes, process parameters, methods, products, compositions of matter, improvements, formulas, algorithms, literary, graphical or audiovisual works or sound recordings, mask works, computer programs, data, documentation, information, know-how, fabrication techniques, technical plans, instructions, manuals, customer lists, price lists, supplier lists, business plans, marketing plans, financial information, and the like, in whatever form or medium, and whether or not designated or marked "Confidential" or the like, that relates to the business of Manchac or the design, manufacture, sale or use of DOSIS or software related thereto, and that is not generally known to the general public or to Manchac's trade or industry.

3.6. Software License Agreement. All software included as part of DOSIS is licensed to Subscriber for use during the term of this Agreement. EXCEPT AS EXPRESSLY AUTHORIZED WITHIN THIS AGREEMENT, CUSTOMER SHALL NOT: COPY, IN WHOLE OR IN PART, SOFTWARE OR DOCUMENTATION; MODIFY THE SOFTWARE; REVERSE COMPILE OR REVERSE ASSEMBLE ALL OR ANY PORTION OF THE SOFTWARE; OR RENT, SUBSCRIBE, DISTRIBUTE, SELL, OR CREATE DERIVATIVE WORKS OF THE SOFTWARE.

Subscriber agrees that aspects of the licensed materials, including the specific design and structure of individual programs, constitute trade secrets and/or copyrighted material of Manchac. Customer agrees not to disclose, provide, or otherwise make available such trade secrets or copyrighted material in any form to any third party without the prior written consent of Manchac.

Customer agrees to implement reasonable security measures to protect such trade secrets and copyrighted material. Title to Software and documentation shall remain solely with Manchac.

3.6.1. Open Code Disclaimer. This disclaimer is presented to comply with the rules of the Open-Source Initiative (OSI), a California public benefit corporation founded in 1998. Open code was developed to allow programmers and users the freedom to share a widely accepted, stable programming language. Programmers and users are allowed to make changes to the open code or to develop new programs using the open code and to redistribute those changes as free or fee-based proprietary programs. To comply with open code standards as established by the OSI, Manchac hereby provides notice that users of the DOSIS System have the right to receive copies of the open-source code Manchac utilizes for DOSIS.

The DOSIS® System was developed using an open code and it is distributed under the Open-Source Definition, a current definition of which may be found at The Open Source Definition - https://opensource.org/osd .

The redistribution and use in source and binary forms of open code, with or without modification, are permitted provided that the following conditions are met:

• Redistributions of source code must retain this notice, this list of conditions, and the following disclaimer.

Page 3 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024

• Redistributions in binary form must provide access to this notice, this list of conditions, the following disclaimer, and the underlying source code.

• All modifications to this software must be clearly documented and are solely the responsibility of the agent making the modifications.

3.6.2. Data Collection and Use. Manchac uses data collected from DOSIS to monitor performance and to communicate with Subscriber. Manchac may also use this data to create aggregated information that does not allow Subscriber to be personally identified or contacted . The parties acknowledge and agree that any such data does not include protected health information.

Subscriber agrees that Manchac may collect data from Subscriber's DOSIS System to monitor unit performance and to communicate with Subscriber.

3.7. Taxes, Duty, and Permits. All prices quoted, unless otherwise specified; do not include any sales, use, inventory, excise, or occupational tax, or any other federal, state, or municipal tax or permit fees imposed on DOSIS System or its use. The amount of any such taxes or fees which are payable in accordance with the provision of any statute, or the rules, regulations, or decisions of any taxing authority, and whether assessed or levied against Subscriber or Manchac, will be paid by Subscriber, either directly to the taxing authority or by reimbursing Manchac for the amount of such taxes as shown on an invoice. Subscriber is not subject to sales tax pursuant to R.C. 5739.02.

3.8. Limitations on Liability. Subscriber hereby agrees DOSIS is a tool used to fill prescriptions. The ultimate responsibility for accurately filling prescriptions remains with Subscriber .. Subscriber is responsible for damages caused solely by its negligent acts and omissions as determined by the Ohio Court of Claims or as the parties may mutually agree.

IN NO EVENT SHALL EITHER OF THE PARTIES HERETO BE LIABLE TO THE OTHER FOR ANY PUNITIVE, CONSEQUENTIAL, EXEMPLARY, INCIDENTAL OR SPECIAL DAMAGES ARISING FROM THE BREACH OF THIS AGREEMENT, BREACH OF ANY WARRANTIES (EXPRESS OR IMPLIED) RELATED TO THE OF DOSIS AND RELATED SOFTWARE AND OTHER LICENSED PRODUCTS, OR FROM ANY SERVICES PROVIDED HEREUNDER, INCLUDING BUT NOT LIMITED TO CLAIMS FOR LOST PROFITS OR OTHER

ECONOMIC DAMAGES.

3.9. DOSIS Warranty. During the term of this Agreement and in consideration for the timely payment of the Monthly Subscription Payment, when applicable, Manchac agrees to provide the technology and services as listed in Exhibit Band further defined in Section 1 as Customer Care Services. IF (A) THROUGH NON-PAYMENT OF SUBSCRIBER, THE TERM OF THIS AGREEMENT IS ALLOWED TO LAPSE, (B) SUBSCRIBER OTHERWISE USES DOSIS SYSTEM OR THE SOFTWARE AND OTHER LICENSED PRODUCTS RELATED THERETO IN ANY MANNER OTHER THAN AS SPECIFIED BY MANCHAC IN WRITING, OR (C) ANY PERSON OTHER THAN MANCHAC PERFORMS SERVICES ON OR MODIFIES IN ANY WAY DOSIS SYSTEM OR THE SOFTWARE RELATED THERETO OR ANY OTHER LICENSED PRODUCT, THEN ALL WARRANTIES, BOTH EXPRESS AND IMPLIED, RELATED TO THE USE OF DOSIS AND THE SOFTWARE RELATED THERETO AND THE LICENSED PRODUCTS SHALL BE VOID AND WAIVED AUTOMATICALLY. MANCHAC MAKES NO WARRANTY ON EQUIPMENT OR SOFTWARE NOT PROVIDED BY MANCHAC OR APPROVED AS CERTIFIED REPLACEMENT PARTS BY MANCHAC. MANCHAC WILL NOT BE RESPONSIBLE FOR DAMAGES TO DOSIS CAUSED BY USER ERROR OR FORCE MAJEURE EVENT. EXCEPT FOR THE EXPRESS WARRANTIES STATED HEREIN, MANCHAC DISCLAIMS ALL WARRANTIES WITH REGARD TO MANCHAC'S PRODUCTS INCLUDING ALL

IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS.

3.10. Entire Agreement and Non-Waiver. This Agreement constitutes the entire Agreement of the parties hereto with respect to the subject matter(s) of this Agreement, and supersedes any other agreements, negotiations, understandings, communications, and representations, whether written or oral. No term or provision of this Agreement shall be amended, supplemented, modified, or waived except by a writing signed by the party against whom such amendment, supplement, modification, or waiver is sought to be enforced.

3.11. Notices. All notices required or permitted by this Agreement, unless specifically provided otherwise, shall be given in writing by certified or registered mail with return receipt requested, by hand delivery, or electronic mail (email) . Any such notice shall be deemed to have been given on the date when such certified or registered mail, electronic mail delivery confirmed, or hand delivery was received and receipted for. All notices to Subscriber should be addressed as listed on first page of this Agreement.

All notices to Manchac shall be addressed to: Manchac Technologies, LLC, Attn : Contracts Admin, 1115 Second Street, Alexandria, LA 71301 or to contracts@manchac.com.

3.12. Force Majeure. Subscriber shall not hold Manchac responsible for any delay or failure of performance occasioned or caused by Force Majeure, which includes, but is not limited to, acts of God, acts of the public enemy's or any Government, acts of any public authority, whether national or international or otherwise, unforeseeable strikes, lockouts, riots or civic commotion, insurrection, fire, flood, or the elements, embargoes, failure of carriers, unavoidable inability to obtain materials or transportation facilities, governmental tariffs or quotas, compliance with any changed law, regulation or other governmental or court order, whether or not valid, or other causes beyond the control of the party.

3.13. Assignment. Subscriber may not transfer or assign any of its rights or obligations under this Agreement without the prior written consent of Manchac, except as part of the sale of substantially all the assets of Subscriber's pharmacy or pharmacy

Page 4 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024 operation to another operating pharmacy. Subject to the foregoing, this Agreement will be binding upon and inure to the benefit of the parties hereto, their successors and assigns.

3.14. Severability. In the event that any provisions of this document shall be declared invalid or unenforceable by a court of competent jurisdiction, the parties agree that the other provisions herein shall survive said declaration. If any court of competent jurisdiction shall determine that any term used herein is invalid or unenforceable, then such term shall be replaced by the acceptable term which is most nearly coextensive with such stricken term.

3.15. Headings. Headings in this Agreement are for the purpose of convenience only. They are not intended to be a material part of the Agreement, and in the event of any inconsistency between the heading and the text, the text shall govern.

3.16. Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent. Words singular and plural in number will be deemed to include the other and pronouns having masculine or feminine gender will be deemed to include the other. If the Agreement is found to be vague or unclear regarding any matter, both parties agree to work together in good faith to establish mutual intent.

3.17. Incorporation of Exhibits and Addendum. The Exhibit(s), Schedules, Appendices, and Addendum (hereinafter "Exhibits and Addendum") identified in this Agreement are incorporated herein by reference and made a part hereof. Any inconsistency between this Agreement and any Exhibit(s) or Addendum shall be read so as to provide a single, harmonious interpretation to the degree possible; if this is not possible and a direct conflict remains, the text of the Addendum shall control (but only to the extent of such direct conflict).

3.18. Governing Law/Jurisdiction. THE VALIDITY, CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT OF THIS AGREEMENT ARE GOVERNED BY THE LAWS OF THE STATE OF OHIO, WITHOUT REGARD TO CHOICE OF LAW PROVISIONS. EACH PARTY TO THIS AGREEMENT CONSENTS AND AGREES THAT THE OHIO COURT OF CLAIMS IS THE PROPER VENUE FOR LITIGATION AGAINST SUBSCRIBER SEEKING MONETARY DAMAGES FOR BREACH OF THE AGREEMENT. OTHERWISE MANCHAC CONSENTS TO

JURISDICTION IN A COURT OF PROPER JURISDICTION IN FRANKLIN COUNTY, OHIO.

3.19. Use of Name, Logo. Notwithstanding any other provision of this Agreement to the contrary, the trademark "DOSIS®" and all logos of Manchac shall remain the sole and exclusive property of Manchac, and Subscriber may not use such trademark or logos without the express written consent of Manchac.

3.20. Counterparts. This Agreement may be executed in one or more counterparts, and by each party on separate counterparts, each of which shall be considered an original, and all such counterparts together shall constitute one and the same instrument.

This Agreement is subject to approval by an executive officer of Manchac at its office at Alexandria, Louisiana, and, if accepted by Subscriber, shall become a binding contract when, and only when, it is approved in writing by such executive officer at said home office. Transmission or receipt of this Agreement by facsimile (FAX), email or other means of communication or duplication, bearing a reproduction of a signature or initial shall have the same validity and legal result as do original signatures or initials.

SECTION 4- MINIMUM SITE REQUIREMENTS

4.1. Pharmacy Environment: The DOSIS System must be installed in a dry, indoor environment that is clean and free of drafts and direct sunlight. The ambient temperature around each tower should be between 65-75 °F with a relative humidity between 20 and 80 percent. The operating environment should be free of condensation and relatively free of dust.

4.2. Space & Weight Requirements: Specific requirements for each system will be provided during pre-installation documentation, but Subscriber should plan for the following dimensions and weights.

• Product Dimensions (height x width x depth): Each DOSIS tower is 79.5 in. x 44 in. x 26 in . Allow a minimum of 4 in. of clearance on each side and the rear of the cabinet and at least 24 in. of clearance in the front.

• Product Dead Weight: Each DOSIS tower weights approx. 1,200 lbs. The pharmacy floor must be sturdy enough to support the full weight of the cabinet as well as any additional equipment and people in the immediate vicinity.

• Entrance and Hallway Clearance (Turn Radius): Entry into the pharmacy requires enough room to maneuver each DOSIS tower (reference dimensions above). A common issue is too small of doorway height clearance due to thresholds and locking mechanisms attached to door frames. Additional charges may apply if installations involve stairways or other obstacles which require specialty moving equipment.

4.3. Power Requirements: A minimum of one dedicated 120 VAC outlet at 20 amp is required for each DOSIS tower. Power specifications for each tower are 20-amp, 120 VAC +/- 10% @ 50/60 Hz+/- 1%. Power consumption is a maximum of 2200 watts for each DOSIS tower.

4.4. Technology Requirements: Pharmacy is responsible for providing the following connectivity. Specific requirements for each system will be provided during pre-installation documentation.

• Pharmacy Management Software, including pharmacy automation interface

• Broadband Internet Access: Continuous connection; minimum 120 Kbit/s bandwidth.

Page 5 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024

Docusign Envelope ID: 1E4D5776-4C05-4949-B818-EAE335D182D1

D@SIS*svstems

• Ethernet local area network connection for each device of DOSIS System.

4.5. Safety Requirements: The frame of each DOSIS tower should be bolted to the floor or wall to ensure stable installation and prevent tip-over. Subscriber must inform Manchac of its preference for wall-mount or floor-mount during the pre-installation period and ensure structure of wall or floor of pharmacy is sufficient to meet weight loads as listed above.

SECTION 5 - INCLUDED EXHIBITS AND ADDENDUM

The following Exhibits supersedes all previous Exhibits and agreed upon pricing.

• Exhibit A: Pharmacy Information

• Exhibit B: Purchase Order and Monthly Subscription Rate

• Addendum: State of Ohio Terms and Conditions

In witness hereof, the parties hereto have caused this Agreement to be duly executed as of the date first written below, to become effective on the date of second signature below.

Manchac Technologies

G Signedby:

By: Y ~e~~~

Steve Warden

PRINTED

TITLE

10-01-2025 ! 12:37:39 PDT

DATE

Subscriber

Timothy Bodle

PRINTED

Cbiet Obia Pharmacy Services

TITLE

10-06-2025 110:50:26 CDT

DATE

Page 6 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024

Docusign Envelope ID: 1E4D5776-4C05-4949-B818-EAE335D182D1

D (i)SIS*svstems

EXHIBIT A - Pharmacy Information

Pharmacy Name: Ohio Pharmacy Services - Central Pharmacy Inpatient

Pharmacy Phone Number: (614) 752-0176

Pharmacy Hours of Operation (Days & Hours): Monday- Friday 6:00AM - 7:30PM EST

Pharmacy PMIS Host System: Fusion CIPS

Pharmacy's Physical Delivery Address

Street, City, State, ZIP: 2150 West Board St. Columbus, OH, 43223

Pharmacy's Primary DOSIS Project Contact

Name: Richard Ives Phone: (614) 644-1364

Email : richard.ives@mha.ohio.gov Title:IPharmacy Operations Manager

Pharmacy's Point of Contact for Billing:

Name: Kimberley Samson Phone: (614) 752-0114

Email: Kimberley.Samson@mha.ohio.gov Title:IFinancial Analyst Supervisor

Billing Address: 2150 West Board St. Columbus, OH, 43223

Pharmacy's Point of Contact for Sales and Use Taxes:

Name: Kimberley Samson Phone: (614) 752-0114

Email: Kimberley.Samson@mha.ohio.gov Title: Financial Analyst Supervisor

Page 7 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH Manchac Technologies, LLC Rev.11/2024

New Monthly Subscription Rates & Payment Schedule

Software License Agreement: as defined in Section 3. 6 DOSIS Customer Care Services: as defined in Section 1

Time Pass Printing; Directional Printing; Narc Admin Printing; Additional Canisters; Pre-Pack Manager; Unit-Dose Printing on back

Due on or before the first of each month Per Section 2.1, automated payment of monthly subscription is required

Monthly subscription rate is subject to change with 30-days written notice by Manchac

Docusign Envelope ID: 1E4D5776-4C05-4949-B818-EAE335D182D1

EXHIBIT B - Monthly Subscription Rate Pricing effective January 1, 2026.

DOSIS TECHNOLOGY and SERVICES COVERED:

Purchased Technology and Monthly Service Rate:

• DOSIS Dispensing Tower: D615, D616, D617, D618, D641, D642, D643, D787

816 Medication canisters Local site server, label printer, and bar code scanner

SERVICES and TECHNOLOGY NOT COVERED:

Payment Schedule:

(To be determined upon billing) Sales Taxes:

(Plus, salestaxTBD) New Monthly Subscription Rate Total:

Page 8 of 8 20056 - Ohio Department of Behavioral Health - Columbus, OH

D(i)SIS*svstems

Quantity Price (each) Total

$1,100 $8,800

$0

$8,800

Manchac Technologies, LLC Rev.11/2024

$1,050 $8,400

$8,400